脑部放疗,上午比下午敏感许多!3 v" O: \' v2 s7 Q0 ^3 x' y* ?
" l$ q& u/ u# X4 V7 x9 O" g+ W7 X! C8 W/ t
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
& X( ?% l8 ]7 H) G1 `0 M- z5 D( dGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
3 u& G* F" O1 J& j% n8 E- TRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
$ Y7 I$ Q3 t3 E( q& q$ d9 rSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.+ ^) y. n7 {) ]: w) r
- d& C6 c/ \- a' jAbstract
$ j2 b; P( h/ M6 CBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
( t! i) O' f% |% h. k* W+ y* M- B1 h1 F! y
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic./ s! Q: c) @; q; d
8 }# j( z6 A# A9 E3 v; ]1 h' ~# pRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
, e4 V% [7 |2 X' D3 f' C4 z# v& ?3 z( ^/ P2 Z
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.6 T m0 D3 j3 m1 |# T7 G% D) e
" c3 @5 b8 P! `/ ~
|